COGT - Cogent Biosciences, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$50.00
DETAILS
HIGH:
$60.00
LOW:
$35.00
MEDIAN:
$52.00
CONSENSUS:
$50.00
UPSIDE:
53.05%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 7.9 | 22.5 | 9.7 | 8.4 | 6.4 | 3.0 |
| Cost of Revenue | 4.6 | 0 | 0 | 0 | 0 | 25.7 | 0.0 | 0 | 0 | 0 | 0 |
| Gross Profit | (4.6) | 0 | 0 | 0 | 0 | (17.9) | 22.5 | 9.7 | 8.4 | 6.4 | 3.0 |
| Operating Expenses | |||||||||||
| R&D Expenses | 269.8 | 232.7 | 173.8 | 121.6 | 55.9 | 72.6 | 43.7 | 38.3 | 29.8 | 22.0 | 6.9 |
| SG&A Expenses | 63.6 | 43.3 | 34.4 | 26.2 | 19.6 | 17.4 | 11.0 | 7.5 | 4.7 | 3.4 | 2.7 |
| Other Expenses | (4.6) | 0 | 0 | 0 | 0 | (25.7) | 0.1 | 0.3 | 0.3 | 0 | 0 |
| Operating Expenses | 328.7 | 275.9 | 208.1 | 147.8 | 75.6 | 64.3 | 54.7 | 45.7 | 34.5 | 25.4 | 9.6 |
| Operating Income | |||||||||||
| Operating Income | (333.4) | (275.9) | (208.1) | (147.8) | (75.6) | (82.2) | (32.2) | (36.0) | (26.2) | (19.1) | (6.6) |
| Interest Expense | 3.1 | 0 | 0 | 4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 14.7 | 18.1 | 13.1 | 4.0 | 0.5 | 0.1 | 0.3 | 1.2 | 0.4 | 0.3 | 0 |
| Profitability | |||||||||||
| EBITDA | (328.7) | (271.6) | (204.5) | (142.0) | (73.6) | (34.6) | (30.9) | (34.7) | (25.0) | (18.2) | (6.4) |
| EBIT | (333.4) | (275.9) | (208.1) | (147.8) | (75.6) | (35.3) | (32.2) | (36.0) | (26.2) | (19.1) | (6.6) |
| Income Before Tax | (328.9) | (255.9) | (192.4) | (140.2) | (72.3) | (74.8) | (31.8) | (34.5) | (25.5) | (18.1) | (6.6) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (328.9) | (255.9) | (192.4) | (140.2) | (72.3) | (74.8) | (30.3) | (34.5) | (25.5) | (18.1) | (6.6) |
| Per Share Data | |||||||||||
| EPS (Basic) | -2.55 | -2.46 | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 | -3.45 | -3.10 | -1.13 |
| EPS (Diluted) | -2.55 | -2.46 | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 | -3.45 | -2.45 | -0.89 |
| Shares Outstanding | 67.6 | 103.9 | 79.7 | 58.7 | 38.7 | 11.1 | 7.6 | 6.2 | 7.4 | 5.9 | 5.9 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 312.0 | 98.2 | 53.2 | 139.9 | 219.7 | 242.2 | 37.4 | 55.7 | 28.3 | 41.3 |
| Short-Term Investments | 588.8 | 188.9 | 212.5 | 119.4 | 0 | 0 | 0 | 22.9 | 12.7 | 27.2 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1.7 | 0.8 | 0.9 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| Other Current Assets | 9.6 | 9.4 | 5.1 | 1.3 | 0 | 0 | 0 | 0.7 | 0.1 | 0 |
| Total Current Assets | 910.4 | 296.5 | 270.8 | 265.0 | 222.6 | 244.9 | 40.6 | 81.0 | 42.4 | 69.7 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 23.5 | 26.6 | 30.3 | 31.1 | 4.5 | 4.7 | 7.2 | 3.3 | 4.1 | 4.6 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 7.5 | 0 | 0 | 0 | 0 | 1.3 | 1.3 | 1.3 |
| Other Non-Current Assets | 3.7 | 4.9 | 4.9 | 4.7 | 5.0 | 1.3 | 1.7 | 0.4 | 1.4 | 0 |
| Total Non-Current Assets | 27.3 | 31.4 | 42.7 | 35.8 | 9.5 | 6.0 | 8.8 | 4.9 | 6.7 | 5.8 |
| Total Assets | 937.6 | 327.9 | 313.4 | 300.8 | 232.1 | 250.9 | 49.4 | 85.9 | 49.1 | 75.5 |
| Current Liabilities | ||||||||||
| Account Payables | 9.5 | 12.0 | 10.7 | 5.8 | 3.5 | 0.7 | 3.2 | 1.5 | 1.3 | 1.5 |
| Short-Term Debt | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 1.7 | 3.1 | 0 | 1.3 | 17.9 | 6.9 | 6.0 |
| Other Current Liabilities | 52.9 | 12.6 | 10.3 | 6.5 | 3.6 | 7.3 | 3.4 | 3.9 | 1.6 | 0.1 |
| Total Current Liabilities | 64.0 | 55.7 | 38.2 | 26.8 | 17.1 | 13.1 | 13.2 | 24.9 | 11.2 | 8.7 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 237.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | (14.3) | 0 | 0 | 0 | 0 | 0 | 0 | 0.7 | 0.9 | 0.9 |
| Total Non-Current Liabilities | 237.3 | 15.9 | 17.5 | 18.2 | 0.8 | 3.2 | 4.4 | 0.7 | 9.6 | 14.4 |
| Total Liabilities | 301.2 | 71.6 | 55.6 | 45.1 | 17.9 | 16.2 | 17.7 | 25.7 | 20.8 | 23.2 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (1,188.4) | (859.5) | (603.6) | (411.2) | (271.0) | (198.7) | (123.9) | (92.1) | (51.3) | (25.8) |
| Accumulated Other Comprehensive Income | 0.4 | 0.4 | 0.2 | (0.1) | 0 | 0 | 0 | (0.0) | (0.0) | (0.0) |
| Total Stockholders' Equity | 636.4 | 256.3 | 257.8 | 255.7 | 214.2 | 234.7 | 31.8 | 60.2 | 28.3 | 52.4 |
| Total Liabilities & Equity | 937.6 | 327.9 | 313.4 | 300.8 | 232.1 | 250.9 | 49.4 | 85.9 | 49.1 | 75.5 |
| Debt Metrics | ||||||||||
| Total Debt | 253.2 | 17.5 | 18.9 | 19.6 | 3.2 | 5.2 | 6.0 | 0 | 0 | 0 |
| Net Debt | (58.9) | (80.7) | (34.4) | (120.2) | (216.5) | (237.0) | (31.4) | (55.7) | (28.3) | (41.3) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (328.9) | (255.9) | (192.4) | (140.2) | (72.3) | (74.8) | (31.8) | (34.5) | (25.5) | (18.1) |
| Depreciation & Amortization | 4.6 | 4.4 | 3.6 | 5.9 | 0.1 | 0.7 | 1.3 | 1.3 | 1.2 | 0.8 |
| Stock-Based Compensation | 46.1 | 39.7 | 30.6 | 18.4 | 11.7 | 6.0 | 3.2 | 3.1 | 1.3 | 1.0 |
| Change in Working Capital | 8.0 | 11.6 | 11.4 | 0.8 | 2.0 | (5.3) | (14.1) | (2.2) | (2.9) | (2.3) |
| Other Non-Cash Items | 5.8 | (7.6) | (6.9) | (3.4) | (0.3) | 37.5 | (0.1) | 0.0 | 0.0 | (0.1) |
| Operating Cash Flow | (264.4) | (207.8) | (153.6) | (118.6) | (58.8) | (35.9) | (41.5) | (32.5) | (25.8) | (18.6) |
| Investing Activities | ||||||||||
| Capital Expenditure | (1.6) | (0.6) | (2.8) | (6.9) | (1.7) | 0 | (0.0) | (0.5) | (0.9) | (3.3) |
| Acquisitions | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.2 | 0 | 0 | 0 |
| Purchases of Investments | (687.2) | (255.6) | (348.8) | (177.9) | 0 | 0 | 0 | (47.7) | (6.5) | (55.2) |
| Sales/Maturities of Investments | 289.2 | 294.5 | 253.8 | 60 | 0 | 0 | 23.0 | 37.7 | 21 | 28 |
| Other Investing Activities | 0 | 0 | 0 | (0.1) | 0 | 8.4 | 0 | 0 | (0.1) | 0.1 |
| Investing Cash Flow | (399.5) | 38.3 | (97.8) | (124.7) | (1.7) | 8.4 | 23.2 | (10.5) | 13.5 | (30.4) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 215.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (48.9) | 1.1 | 0 | 1.6 | (0.0) | 0.6 | 0 | (1.4) | (0.8) | (0.0) |
| Financing Cash Flow | 878.2 | 214.5 | 163.5 | 163.6 | 38.0 | 232.2 | 0.1 | 70.3 | (0.7) | (0.0) |
| Cash Position | ||||||||||
| Net Change in Cash | 214.3 | 44.9 | (87.9) | (79.8) | (22.5) | 204.8 | (18.2) | 27.3 | (13.1) | (49.1) |
| Cash at Beginning | 98.2 | 53.2 | 141.1 | 220.9 | 243.4 | 38.7 | 55.7 | 29.6 | 41.3 | 90.4 |
| Cash at End | 312.4 | 98.2 | 53.2 | 141.1 | 220.9 | 243.4 | 37.4 | 56.9 | 28.3 | 41.3 |
| Free Cash Flow | (266.0) | (208.4) | (156.4) | (125.5) | (60.5) | (35.9) | (41.5) | (33.0) | (26.7) | (21.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 7.9 | 22.5 | 9.7 | 8.4 | 6.4 | 3.0 |
| Gross Profit | (4.6) | 0 | 0 | 0 | 0 | (17.9) | 22.5 | 9.7 | 8.4 | 6.4 | 3.0 |
| Operating Income | (333.4) | (275.9) | (208.1) | (147.8) | (75.6) | (82.2) | (32.2) | (36.0) | (26.2) | (19.1) | (6.6) |
| Net Income | (328.9) | (255.9) | (192.4) | (140.2) | (72.3) | (74.8) | (30.3) | (34.5) | (25.5) | (18.1) | (6.6) |
| EPS (Diluted) | -2.55 | -2.46 | -2.42 | -2.26 | -1.85 | -6.00 | -3.97 | -5.55 | -3.45 | -2.45 | -0.89 |
| Balance Sheet | |||||||||||
| Cash & Equivalents | 312.0 | 98.2 | 53.2 | 139.9 | 219.7 | 242.2 | 37.4 | 55.7 | 28.3 | 41.3 | |
| Total Assets | 937.6 | 327.9 | 313.4 | 300.8 | 232.1 | 250.9 | 49.4 | 85.9 | 49.1 | 75.5 | |
| Total Debt | 253.2 | 17.5 | 18.9 | 19.6 | 3.2 | 5.2 | 6.0 | 0 | 0 | 0 | |
| Stockholders' Equity | 636.4 | 256.3 | 257.8 | 255.7 | 214.2 | 234.7 | 31.8 | 60.2 | 28.3 | 52.4 | |
| Cash Flow | |||||||||||
| Operating Cash Flow | (264.4) | (207.8) | (153.6) | (118.6) | (58.8) | (35.9) | (41.5) | (32.5) | (25.8) | (18.6) | |
| Capital Expenditure | (1.6) | (0.6) | (2.8) | (6.9) | (1.7) | 0 | (0.0) | (0.5) | (0.9) | (3.3) | |
| Free Cash Flow | (266.0) | (208.4) | (156.4) | (125.5) | (60.5) | (35.9) | (41.5) | (33.0) | (26.7) | (21.9) | |